E Fund Management Co., Ltd. Pmv Pharmaceuticals, Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.17 - $12.95 $49,020 - $77,700	-6,000 Reduced 30.18%	13,884 $121,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $86,833 - $130,860	-7,617 Reduced 27.7%	19,884 $237,000
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $243,939 - $592,802	26,429 Added 2465.39%	27,501 $392,000
Q1 2021 May 12, 2021	BUY	$30.66 - $49.5 $32,867 - $53,064	1,072 New	1,072 $35,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.